CEDAR KNOLLS, N.J., Feb. 3, 2009 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (Nasdaq:EMIS), a biopharmaceutical company that focuses on a unique and improved delivery of therapeutic molecules using its Eligen(r) Technology, today announced that President and Chief Executive Officer, Michael V. Novinski, will present at the 11th Annual BIO CEO & Investor Conference at 11:30 AM EST on Tuesday, February 10, 2009. The BIO CEO Conference is being held at the Waldorf-Astoria Hotel in New York City.
